Designing of immunotherapeutics, utilising patient derived dendritic cells generated hope for personalised melanoma vaccine. To provide sufficient immune signals, these dendritic cells are transfected with potential tumour associated antigens. Here we provide a computational pipeline to find the minimal set of epitopes based on patient haplotypes and patient specific mutation profile that help in simulating cytotoxic T cell mediated immunity.We identified over expressed proteins and proteins with validated melanoma associated mutations to predict novel tumour associated antigens. For our analysis, we considered MHC class-1 HLA allele frequency data from the German population eight (www.allelefrequencies.net). For epitopes with known mutations in melanoma, we generated 3D structures and performed molecular docking and molecular dynamics simulation analysis to understand the impact of mutation on their binding affinity with HLA alleles and T-cell receptor.Using our computational analysis, we identified unique epitopes from proteins MCSP, MAGE-A3, Melan-A and survivin overexpressed in melanoma. We also used BRAF, NRAS, RAC1, KIT, STK19, MAP2K1 and CTNNB1 proteins with known mutations in case of melanoma.Our computational workflow is able to identify novel epitope sets with high confidence for experimental validations.